| Date Filed | Type | Description |
| 02/07/2023 |
4
| Valamehr Bahram (Chief R&D Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 450,000 options to buy
@ $6.77, valued at
$3M
|
|
| 01/13/2023 |
4
| Valamehr Bahram (Chief R&D Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Exercised 423 options to buy
@ $1.37, valued at
$579.5 |
|
| 01/11/2023 |
4
| Valamehr Bahram (Chief R&D Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 10,917 shares
@ $5.24, valued at
$57.2k
|
|
| 07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2022 |
4
| Valamehr Bahram (See Remarks) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 33,302 shares
@ $0
Granted 53,058 options to buy
@ $39.87, valued at
$2.1M
|
|
| 01/13/2022 |
4
| Valamehr Bahram (Chief R&D Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 4,152 shares
@ $48.44, valued at
$201.1k
Sold 418 shares
@ $49.12, valued at
$20.5k
|
|
| 01/12/2022 |
4
| Valamehr Bahram (Chief R&D Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 5,245 shares
@ $46.33, valued at
$243k
Sold 351 shares
@ $47.17, valued at
$16.6k
|
|
| 12/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2021 |
4
| Valamehr Bahram (Chief R&D Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 60,958 shares
@ $0 |
|
| 09/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/15/2020 |
4
| Valamehr Bahram (Chief Development Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 1,813 shares
@ $95.8947, valued at
$173.9k
Sold 11,765 shares
@ $96.6546, valued at
$1.1M
Sold 2,946 shares
@ $97.6959, valued at
$287.8k
Sold 3,148 shares
@ $98.7969, valued at
$311k
Sold 3,822 shares
@ $99.7685, valued at
$381.3k
Sold 400 shares
@ $100.97, valued at
$40.4k
Sold 1,006 shares
@ $102.063, valued at
$102.7k
Sold 100 shares
@ $102.75, valued at
$10.3k
Exercised 25,000 options to buy
@ $2.9, valued at
$72.5k
|
|
| 09/16/2020 |
4
| Valamehr Bahram (Chief Development Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 600 shares
@ $34.6533, valued at
$20.8k
Sold 16,784 shares
@ $36.0256, valued at
$604.7k
Sold 7,016 shares
@ $36.9277, valued at
$259.1k
Sold 600 shares
@ $37.49, valued at
$22.5k
Exercised 3,076 options to buy
@ $1.69, valued at
$5.2k
Exercised 21,924 options to buy
@ $2.9, valued at
$63.6k
|
|
| 02/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/10/2020 |
4
| Valamehr Bahram (Chief Development Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 25,000 shares
@ $0
Sold 5,700 shares
@ $20.6925, valued at
$117.9k
Granted 90,000 options to buy
@ $21.99, valued at
$2M
|
|
| 10/16/2019 |
4
| Valamehr Bahram (Chief Development Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Sold 6,200 shares
@ $14.1759, valued at
$87.9k
|
|
| 01/09/2019 |
4
| Valamehr Bahram (Chief Development Officer) has filed a Form 4 on FATE THERAPEUTICS INC|
Txns:
| Granted 45,000 shares
@ $0
Granted 135,000 options to buy
@ $16.55, valued at
$2.2M
|
|
| 08/07/2018 |
3
| Valamehr Bahram (Chief Development Officer) has filed a Form 3 on FATE THERAPEUTICS INC |